Statutory Menstrual Leave

Bell Ribeiro-Addy Excerpts

Monday 13th April 2026 Westminster Hall

[Dr Scott Arthur (Edinburgh South West) (Lab)]

You will not be surprised to hear me say, Mr Mundell, that it is a pleasure to serve under your chairmanship. I thank my hon. Friend the Member for Colne Valley (Paul Davies) for the way in which he introduced this debate, and other hon. Members for the excellent speeches that followed.

I recently met a constituent who lives in Chesser and has adenomyosis. During our meeting, she told me about the debilitating impact of the condition on her personal life and her work life, and it was a real insight for me. On some days, her pain is so severe that she struggles to walk or move around her home, even to reach the toilet. She also reminded me just how common endometriosis and adenomyosis are: given that around 10% of menstruators suffer from one of the two conditions, there could be thousands of people in Edinburgh South West who currently suffer from the regular and excruciating pain that they cause.

Although my constituent now has an employer who understands and accommodates her health needs and allows her to work from home or take leave for her condition, that has not always been the case. She recounted the degrading experience of having to explain her health issues in detail to a former employer, just for taking time off. Despite that, she was still given a written warning. It is such inconsistency among employers that motivated her to sign the petition and to meet me to ask, very politely, that I attend this debate on her behalf.

As we have already heard, up to one in six women with endometriosis have to leave the workplace due to their condition. For some women, that will be because they really cannot work due to the pain they suffer. Sadly, for other women, who can work and want to work, it may come down to a lack of accommodating workplaces. We have to be honest about that situation and say that it is discrimination.

I recognise the Government’s position that the provisions of the Equality Act 2010 should ensure the flexibility that is required for women affected by these conditions to take leave or for adjustments to be made for them. However, laws are only useful if they are respected and enforced. None the less, I hope that the reforms introduced in the Employment Rights Act 2025, including statutory sick pay, will ensure that further accommodations can be made.

I hope that the Minister will give some guarantee today that the Government will look at menstrual leave schemes abroad to inform the evidence-based best practice that we need in the UK. I also hope that the Government will do what they can to support businesses or organisations that decide to introduce such practice in the interim, simply because it is the right thing to do. I must be honest and say that I had not heard of the endometriosis-friendly employer scheme before, so it would also be interesting to hear what the Government are doing to support that scheme.

The data from the schemes implemented abroad show that they are unlikely to be abused. Although the petition we are discussing today relates to the scheme in Portugal, the introduction of a similar menstrual leave policy in Spain has not led to an avalanche of sick days being taken as a result. Although I know there have been some concerns about how easy it is to access that scheme, the Spanish allowance has been used just 1,550 times. It will hardly have a significant impact on the Spanish economy, but it will be a huge benefit to the women who are able to access it.

Equally, such schemes can help employees avoid having repeatedly to justify in detail absences that they require. With the Portuguese system of requiring only one initial confirmation of diagnosis, employees will likely be spared uncomfortable and degrading conversations with superiors and work colleagues about this medical condition.

I hope the Government will look to the positive impact of those schemes abroad and build up best practice for the UK. I want to make one last point: when I spoke about this debate on my Facebook page, many women who responded said that they were keener for GPs to be better informed about the condition, and for diagnosis to happen much quicker. I could not believe it took just over nine months for a diagnosis to take place—

[Bell Ribeiro-Addy (Clapham and Brixton Hill) (Lab)]

Nine years.

[Dr Arthur]

Nine years—apologies. It took just over nine years for a diagnosis to take place, given the pain we have heard about. We have heard in this debate about the real human impact that delay causes. That must be impacting our economy too, so I hope the Government will commit to studying the effect of these conditions on the economy, and perhaps that will justify action in this domain.

[Bell Ribeiro-Addy (Clapham and Brixton Hill) (Lab)]

It is a pleasure to serve under your chairmanship, Mr Mundell. I thank my hon. Friend the Member for Colne Valley (Paul Davies) for his opening remarks, and for his compassion and solidarity. He is absolutely right that every man should have a say in these issues and challenge them. As well as the fact that nearly half the global population will menstruate at some point in their lifetime, and on any given day 850 million people across the world are menstruating, we are all here because a woman somewhere had a menstrual cycle, so it is a concern for absolutely everybody.

For something so universal, menstruation remains shrouded in coded language, embarrassment and unnecessary shame. We call it “the time of month”, “the painters are in”, “my cousin has come to stay”—anything but what it actually is. We pass around tampons and pads as if they are some sort of contraband that no one should see. That evasion is not accidental: it is the product of centuries of conditioning that told women their bodies were problems to be managed in silence and shame.

Listening to my fellow hon. Friends speaking about their own experience, all I keep thinking is that, if young women had been flagged when they had painful periods, things would have been different for a lot of the conditions we are talking about, certainly in terms of the length of time to diagnosis. I am really pleased to contribute to this debate and support statutory menstrual leave, not as a radical policy but as a practical, compassionate and long-overdue step towards a fairer and healthier working society.

We already see where progress has been made and where things have been championed in this House. I congratulate my hon. Friend the Member for Erith and Thamesmead (Ms Oppong-Asare) on the ten-minute rule Bill she introduced recently and her consistent campaigning for improved endometriosis care. I also congratulate my hon. Friend the Member for Bathgate and Linlithgow (Kirsteen Sullivan) on her work as the chair of the APPG on endometriosis. All that work matters and it is making a difference.

Scotland became the first country in the world to legislate for free menstrual products, and across the UK we rightly abolished VAT on sanitary products in 2021, finally ending the so-called tampon tax. Steps like those matter, but they are not the end of the journey—not by a long way. Here is the truth: we have made it cheaper to menstruate, but we have not made it safe to admit that someone is struggling because of it.

Menstrual stigma continues to socially condition people to conceal their pain, push through it and stay silent at work. The cost of that silence is not abstract; for those living with endometriosis, dysmenorrhoea, adenomyosis or premenstrual dysphoric disorder, that silence means working through debilitating pain or losing earnings when they cannot, and in some cases losing jobs altogether. Those are real conditions. They are painful and often severe, and they exist within a system where female reproductive health has been chronically under-researched, underfunded and far too often dismissed.

[Kirsteen Sullivan]

My hon. Friend is making a very powerful point. Does she agree that the impact on women’s mental health is rarely spoken about? Women feel ignored and dismissed, but they are living in constant pain and the anticipation of it, which just wears them down. The mental health point is rarely acknowledged but must be addressed.

[Bell Ribeiro-Addy]

My hon. Friend is absolutely right. I say that as someone who lives with endometriosis and constantly experiences that pain, thinking about what I can and cannot do, and what I will be able to manage this week or that week. I know what it is to sit in a meeting, stand through our many votes and carry on a role that demands my full presence when my body is screaming otherwise. I know from listening to other Members and so many different women speaking about it that I am far from alone.

It is not a competition of who receives more health funding, but we have to say that men have won consistently. When my hon. Friend the Member for Milton Keynes Central (Emily Darlington) was speaking, I looked up some figures for the amount of investment into things such as Viagra. Everyone should look at them when they can; they are shocking in comparison with what is spent on certain things in men’s and women’s health. Let us be honest about what that under-investment has cost us: endometriosis alone affects around 1.5 million people in the UK, taking an average of nearly nine years to diagnose, as we have heard. That is not a gap in the system, but a failure of the system; it is a failure rooted in a long-standing tendency to deprioritise women’s pain.

Statutory menstrual leave would allow someone to take time off when they were genuinely unable to work due to menstruation, without fear of judgment, without risking their job security and without having to lie about why they are absent. Crucially, it would also begin to normalise the conversation and to challenge the stigma rather than reinforce it, because the answer to workplace discrimination is never to remain invisible.

As we have heard, menstrual leave policies already exist across the globe: in Japan, South Korea, Taiwan, China, Indonesia, Zambia, Mexico and, most recently, Portugal. They are not fringe experiments, but functioning workplace policies in countries with vastly different cultures and economies. The evidence that this is workable is already there. Here at home, our Employment Rights Act has introduced major reforms, including a day one right to sick pay. Menstrual leave would sit naturally alongside those changes if we were to implement it; it is consistent with the direction of travel and is the next logical step.

The policy also offers vital protection for those who are too often overlooked, including transgender men and non-binary and gender-diverse people who menstruate. For many, disclosure of menstrual status can expose them to discrimination or worse. A clear statutory framework would provide safety, privacy and the reassurance that their needs were seen and protected by law.

There are those who argue that menstrual leave would undermine women in the workplace, and that employers would discriminate against people who menstruate when hiring. I take that concern seriously, but that argument has been made against every single piece of workplace equality legislation in history: it was made against maternity leave, it was made against equal pay, and it was made against flexible working. In every case, the answer was not to abandon the protection, but to make the legal framework strong enough to prevent the discrimination. That is what we have to do here too.

The ultimate goal is job security, wellbeing and genuine equality. Menstrual leave alone will not get us all the way there, but it is a serious, evidence-backed and compassionate step in the right direction. I urge this House to take it.